Chimeric antigen receptor-natural killer cell therapy in first-relapse epithelial ovarian cancer: an early health-economic evaluation in the Netherlands.

Saved in:
Bibliographic Details
Title: Chimeric antigen receptor-natural killer cell therapy in first-relapse epithelial ovarian cancer: an early health-economic evaluation in the Netherlands.
Authors: Seyahian A; Science Department IQ Health, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: Abril.Seyahian@radboudumc.nl., Scholte M; Science Department IQ Health, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands., Gravesteijn C; Department of Laboratory Medicine - Laboratory of Hematology, Radboud University Medical Center, Nijmegen, Netherlands., Zusterzeel PLM; Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, The Netherlands., De Jonge PKJD; Department of Laboratory Medicine - Laboratory of Hematology, Radboud University Medical Center, Nijmegen, Netherlands., de Goede A; Department of Pharmacy, Pharmacology and Toxicology, Radboud University Medical Center, Nijmegen, The Netherlands., Jansen JH; Department of Laboratory Medicine - Laboratory of Hematology, Radboud University Medical Center, Nijmegen, Netherlands., Bekkers RLM; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Obstetrics and Gynecology, Catharina Hospital Eindhoven, The Netherlands; GROW School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands., Ottevanger PB; Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, The Netherlands., Dolstra H; Department of Laboratory Medicine - Laboratory of Hematology, Radboud University Medical Center, Nijmegen, Netherlands., Grutters JPC; Science Department IQ Health, Radboud University Medical Center, Nijmegen, The Netherlands.
Source: Cytotherapy [Cytotherapy] 2026 Jul; Vol. 28 (7), pp. 102822. Date of Electronic Publication: 2026 Apr 03.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 100895309 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-2566 (Electronic) Linking ISSN: 14653249 NLM ISO Abbreviation: Cytotherapy Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1477-2566
DOI:10.1016/j.jcyt.2026.102822